Top

Osteoporosis International

Published in:

01-04-2016 | Letter

Proton pump inhibitors and fracture risk: response to comments

Authors: B. Zhou, Y. Huang, H. Li, W. Sun, J. Liu

Published in: Osteoporosis International | Issue 4/2016

Excerpt

Dear Editor, …

Sugiyama T, Torio T, Miyajima T, Kim YT, Oda H (2015) 1 Calcium, proton pump inhibitors, and fracture risk. Osteoporos Int. doi:10.1007/s00198-015-3403-8

Zhou B, Huang Y, Li H, Sun W, Liu J (2015) Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int. doi:10.1007/s00198-015-3365-x PubMedCentral

O’Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118:778–781CrossRefPubMed

Targownik LE, Lix LM, Leung S, Leslie WD (2010) Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology 138:896–904CrossRefPubMed

Wright MJ, Proctor DD, Insogna KL, Kerstetter JE (2008) Proton pump-inhibiting drugs, calcium homeostasis, and bone health. Nutr Rev 66:103–108CrossRefPubMed

Hansen KE, Johnson RE, Chambers KR, Johnson MG, Lemon CC, Vo TN, Marvdashti S (2015) Treatment of vitamin D insufficiency in postmenopausal women: a randomized clinical trial. JAMA Intern Med 175:1612–1621CrossRefPubMedPubMedCentral

Freedberg DE, Haynes K, Denburg MR, Zemel BS, Leonard MB, Abrams JA, Yang YX (2015) Use of proton pump inhibitors is associated with fractures in young adults: a population-based study. Osteoporos Int 26:2501–2507CrossRefPubMedPubMedCentral

Title: Proton pump inhibitors and fracture risk: response to comments
Authors: B. Zhou
Y. Huang
H. Li
W. Sun
J. Liu
Publication date: 01-04-2016
Publisher: Springer London
Published in: Osteoporosis International / Issue 4/2016
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-015-3434-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Proton pump inhibitors and fracture risk: response to comments

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2016

Achieving the protection of high peak bone mass

Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p

Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis

A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study

Association of osteoporosis with genetic variants of circadian genes in Chinese geriatrics

Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion